| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2022 | Mar 15, 2022 | Spyre Therapeutics, Inc. | CFO | Buy | 95.0 | +75,000 | 82.99% | ✗ | $156K |
| Dec 9, 2021 | Dec 13, 2021 | Spyre Therapeutics, Inc. | CFO | Buy | 95.0 | +50,000 | 123.85% | ✗ | $186K |
| Aug 16, 2021 | Aug 18, 2021 | Spyre Therapeutics, Inc. | CFO | Buy | 97.5 | +40,372 | 100.00% | ✗ | $262.7K |